General Western Blot Reagents
Abcam Dinaline, Antineoplastic agent, 50MG
MW 227.26 Da, Purity >98%. Antineoplastic agent. CI-994 precursor (ab142098). Induces reversible changes in amino acid transport, protein metabolism and DNA synthesis. Shows antiproliferative effects and antitumor effects in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam AMI 1, protein arginine methyltransferase inhibitor, 25MG
MW 548.5 Da, Purity =99%. Potent, selective and reversible protein arginine methyltransferase inhibitor (IC₅₀ = 1.63 μM). ROS° scavenger with antioxidant effects (IC₅₀ = 8.3 μM). Inhibits arginine in vitro without competing for the AdoMet binding site. Modulates nuclear receptor-regulated transcription in vivo. Cell-permeable.
The product is subject to the following: Abcam Restricted Use Statement
Abcam 410/450 nm E x tracellular Vesicle Membrane Staining Kit, 100 TestsS
Labeling in < 4 hrs with 30 secs hands-on time using 410/450 nm Extracellular Vesicle Membrane Staining Kit ab314685. 100% antibody recovery.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Dienogest, Steroidal progesterone, 25MG
MW 311.4 Da, Purity >99%. Steroidal progesterone. Non-ethinylated progestin structurally related to testosterone. Anti-androgenic and antiproliferative effects in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Caged MK 801, NMDA receptor open-channel blocker, 10MG
MW 460.49 g/mol, Purity >99%. Caged, potent, selective, non-competitive, irreversible NMDA receptor open-channel blocker. UV-active MK 801 (ab144485, ab120027, ab120028) analog. Shows anticonvulsant effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam beta-Nicotinamide adenine dinucleotide (beta-NAD), P2Y11 agonist., 250MG
MW 663.4 Da, Purity >95%. beta-Nicotinamide adenine dinucleotide (beta-NAD), P2Y11 agonist. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam MIRA-1, p53 inducer, 50MG
MW 183.16 Da, Purity >99%. Novel, nontoxic and selective p53 inducer. Antitumor agent. Promotes tumor cell apoptosis in a mutant p53-dependent manner (IC₅₀ = 10 μM) and prolongs survival. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Gramicidin A, Antibiotic agent, 1MG
MW 1882.3 Da, Purity >90%. Gramicidin A, Antibiotic agent. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam HA-1077 (Fasudil), ROCK2 inhibitor, 10MG
MW 327.8 Da, Purity >98%. ROCK2 inhibitor (IC₅₀ = 1.9 μM). Also shown to inhibit PRK2 (IC₅₀ = 4 μM), MSK1 (IC₅₀ = 5 μM), Rsk2 (IC₅₀ = 15 μM), PKA, p70 S6 Kinase, CaM Kinase and MLCK. Calcium antagonist and vasodilator.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Dodecylglucopyranoside, Non-ionic detergent, 100MG
MW 348.5 g/mol, Purity >99%. Non-ionic detergent for solubilization of membrane-bound proteins in their native state. Long chain alkyl glycopyranoside and a classical nonionic amphiphile surfactant.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Voriconazole (UK-109, 496), anti-fungal agent, 10MG
MW 349.31 Da, Purity >99%. Potent and broad-spectrum anti-fungal agent. Inhibits CYP450-dependent 14-α sterol demethylase, to interfere with ergosterol biosynthesis and inhibit fungal growth. Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Boca Scientific Inc SmartBlock™, 125ml
SmartBlock™ is a BSA-free, peptide-based blocker for saturating free binding sites on plastic surfaces or other protein binding surfaces, removing background and preventing unwanted binding. This reagent was produced by chemically modifying peptides in a specific process that resulted in a peptide solution with strong blocking characteristics. SmartBlock™ has high lot-to-lot consistency that had previously only been obtained by synthetic blockers. For many assays, SmartBlock™ is an economical and reliable alternative to BSA-containing solutions. Problems caused by BSA within blockers, such as BSA-interactions and cross reactivities, can be eliminated by using SmartBlock™.
Abcam Rhodamine 6G bis(o x yethylamino)ethane amide bis(trifluoroacetate), Fluorescent labeling rhodamine, 250MG
MW 772.73 g/mol, Purity >95%. Fluorescent labeling rhodamine for proteomics research. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Triacsin C, acyl-CoA synthetase inhibitor, 100UG
MW 207.27 Da, Purity >90%. Potent, specific acyl-CoA synthetase inhibitor (Ki values are 15 nM and 2 μM for Faa2p and Faa4p respectively). Inhibits synthesis of cholesteryl ester and triacylglycerol in vitro. Vasodilator agent. Orally active. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Q x -314 bromide (N-Ethyllidocaine bromide), Na+ channel blocker, 250MG
MW 343.3 Da, Purity >99%. A membrane impermeable quaternary lidocaine derivative. Blocks voltage-sensitive Na+ conductance when applied intracellularly. Soluble in 1 ml water to give specified mM/ml concentration.
The product is subject to the following: Abcam Restricted Use Statement